Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay
- 1 May 2016
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 322, 398-407
- https://doi.org/10.1016/j.neuroscience.2016.02.057
Abstract
No abstract availableKeywords
Funding Information
- Portuguese Foundation for Science and Technology (JPND/0001/2011)
- JPND
This publication has 35 references indexed in Scilit:
- Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC AssayPLOS ONE, 2013
- Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob diseaseNeurology, 2012
- Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 yearsBrain, 2012
- Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking-induced conversionJournal of General Virology, 2012
- Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective studyBMC Neurology, 2011
- High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion diseaseBMC Neurology, 2011
- Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob DiseasesPLOS ONE, 2011
- Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob diseaseBrain, 2009
- Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosisZeitschrift für Neurologie, 2007
- Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2001